Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
2019 · Cell · 745 citations
https://doi.org/10.1016/j.cell.2019.10.007
U
Uma Borate
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
290
Papers
7.7K
Citations
33
h-index
69
i10-index
Uma Borate is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & Myeloproliferative Neoplasms: Diagnosis and Treatment. The author has an h-index of 33, co-authored 247 publications.
ORCID: 0000-0002-4958-4962Papers by this author
worksProteogenomic and metabolomic characterization of human glioblastoma
2021 · Cancer Cell · 663 citations
https://doi.org/10.1016/j.ccell.2021.01.006
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia
2022 · Cancer Cell · 336 citations
https://doi.org/10.1016/j.ccell.2022.07.002
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States
2023 · Annals of Hematology · 21 citations
https://doi.org/10.1007/s00277-023-05109-5
AML-190: Anti-TIM-3 Antibody MBG453 in Combination with Hypomethylating Agents (HMAs) in Patients with High-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia: A Phase 1 Study
2020 · Clinical Lymphoma Myeloma & Leukemia · 17 citations
https://doi.org/10.1016/s2152-2650(20)30728-x
Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years
2019 · Hematology/Oncology and Stem Cell Therapy · 6 citations
https://doi.org/10.1016/j.hemonc.2019.01.002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat